ORCID as entered in ROS

Select Publications
2025, 'A systematic review on gut microbiota in type 2 diabetes mellitus', in Wu G; Yuan H; Yan L (ed.), The Mechanism in Gut Microbiota of Diabetes and Endocrine Complications: Preventive and Therapeutic Target, Frontiers Media SA, pp. 84 - 100, http://dx.doi.org/10.3389/978-2-8325-6615-2
,2015, 'Commercial weight loss programs and their effectiveness in managing obesity', in Managing and Preventing Obesity, Elsevier, pp. 243 - 255, http://dx.doi.org/10.1533/9781782420996.4.243
,2014, 'Commercial weight loss programs and their effectiveness in managing obesity', in Gill T (ed.), Managing and preventing obesity: behavioural factors and dietary interventions, Woodhead Publishers Limited, Cambridge, UK, pp. 243 - 256, http://store.elsevier.com/product.jsp?isbn=9781782420910&_requestid=490865
,2014, 'Commercial weight loss programs and their effectiveness in managing obesity', in Managing and preventing obesity: behavioural factors and dietary interventions, Woodhead Pub Limited, pp. 372
,2025, 'The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial', Sports Medicine Open, 11, http://dx.doi.org/10.1186/s40798-025-00895-w
,2024, 'Clinical outcomes in people with diabetes-related foot infections: Analysis from a limb preservation service infection database', Journal of Foot and Ankle Research, 17, pp. e12040, http://dx.doi.org/10.1002/jfa2.12040
,2024, 'Adrenal insufficiency in hemodialysis patients—An under-recognized problem: A case series', Hemodialysis International, 28, pp. 229 - 232, http://dx.doi.org/10.1111/hdi.13131
,2024, 'Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial', BMJ Open, 14, pp. e082927, http://dx.doi.org/10.1136/bmjopen-2023-082927
,2024, 'A case of adrenal cortical carcinoma arising from a regularly monitored sub-centimetre adrenal incidentaloma', Endocrinology Diabetes and Metabolism Case Reports, 2024, pp. 23 - 0120, http://dx.doi.org/10.1530/EDM-23-0120
,2024, 'A systematic review on gut microbiota in type 2 diabetes mellitus', Frontiers in Endocrinology, 15, pp. 1486793, http://dx.doi.org/10.3389/fendo.2024.1486793
,2024, 'The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial', Sports Medicine Open, 10, pp. 61 - 61, http://dx.doi.org/10.1186/s40798-024-00727-3
,2022, 'Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial', Sports Medicine Open, 8, pp. 27, http://dx.doi.org/10.1186/s40798-022-00417-y
,2022, 'Diabetic Foot Disease: Managing Cardiovascular Risk', Medicine Today, 11, pp. 37 - 41, https://endocrinologytoday.com.au/et/november-2022
,2021, 'Utilisation of the 2019 IWGDF diabetic foot infection guidelines to benchmark practice and improve the delivery of care in persons with diabetic foot infections', Journal of Foot and Ankle Research, 14, pp. 10, http://dx.doi.org/10.1186/s13047-021-00448-w
,2021, 'Sexual identity in congenital adrenal hyperplasia', Journal of Paediatrics and Child Health, 57, pp. 581 - 583, http://dx.doi.org/10.1111/jpc.14912
,2021, 'The Effect Of Cannabidiol (CBD) On Exercise Physiology And Bioenergetics: A Randomised Controlled Pilot Trial', Medicine & Science in Sports & Exercise, 53, pp. 280 - 280, http://dx.doi.org/10.1249/01.mss.0000762344.41349.83
,2020, 'Effects of α-Cyclodextrin on Cholesterol Control and Hydrolyzed Ginseng Extract on Glycemic Control in People With Prediabetes: A Randomized Clinical Trial', JAMA Network Open, 3, pp. E2023491, http://dx.doi.org/10.1001/jamanetworkopen.2020.23491
,2018, 'Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: The Diabetes and Egg (DIABEGG) Study - Randomized weight-loss and follow-up phase', American Journal of Clinical Nutrition, 107, pp. 921 - 931, http://dx.doi.org/10.1093/ajcn/nqy048
,2017, 'Investigating general medication prescription by general practitioners during a 12-month randomized controlled weight loss trial', Clinical Obesity, 7, pp. 222 - 230, http://dx.doi.org/10.1111/cob.12193
,2016, 'Introduction of New South Wales adult subcutaneous insulin-prescribing chart in a tertiary hospital: its impact on inpatient glycaemic control', Internal Medicine Journal, 46, pp. 1323 - 1328, http://dx.doi.org/10.1111/imj.13229
,2016, 'Raised FGF-21 and triglycerides accompany increased energy intake driven by protein leverage in lean, healthy individuals: A randomised trial', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0161003
,2015, 'Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes', Diabetes Metabolism Research and Reviews, 31, pp. 638 - 645, http://dx.doi.org/10.1002/dmrr.2651
,2015, 'Lump it or leave it [amp] bilateral adrenal macronodular hyperplasia: Case report and clinical insights', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.37.ep1162
,2015, 'The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: The Diabetes and Egg (DIABEGG) study- A 3-mo randomized controlled trial', American Journal of Clinical Nutrition, 101, pp. 705 - 713, http://dx.doi.org/10.3945/ajcn.114.096925
,2014, 'The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery', European Journal of Vascular and Endovascular Surgery, 48, pp. 447 - 451, http://dx.doi.org/10.1016/j.ejvs.2014.07.001
,2013, 'Update on the inaugural Sydney diabetic foot conference 2013', International Journal of Lower Extremity Wounds, 12, pp. 242 - 244, http://dx.doi.org/10.1177/1534734613502050
,2013, 'An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study', Obesity, 21, pp. 1561 - 1570, http://dx.doi.org/10.1002/oby.20414
,2013, 'An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY', Clinical Obesity, 3, pp. 172 - 179, http://dx.doi.org/10.1111/cob.12030
,2012, 'A 12-month, randomised, controlled trial to examine the efficacy of the Korean diet in an Australian overweight and obese population - A follow up analysis', Obesity Research and Clinical Practice, 6, pp. e298 - e307, http://dx.doi.org/10.1016/j.orcp.2012.06.006
,2012, 'A 12-week, randomised, controlled trial to examine the acceptability of the Korean diet and its effectiveness on weight and metabolic parameters in an Australian overweight and obese population', Obesity Research and Clinical Practice, 6, pp. e71 - e83, http://dx.doi.org/10.1016/j.orcp.2011.05.003
,2011, 'The practical value of the metabolic syndrome', Medicine Today, 12, pp. 29 - 34
,2011, 'Testing protein leverage in lean humans: A randomised controlled experimental study', Plos One, 6, http://dx.doi.org/10.1371/journal.pone.0025929
,2011, 'Meal Replacement Products and Very Low Carolie Diets in Adult Obesity', Bulletin of the Royal College of Pathologists, 7, pp. 172 - 173
,2011, 'Primary care referral to a commercial provider for weight loss treatment versus standard care: A randomised controlled trial', Lancet, 378, pp. 1485 - 1492, http://dx.doi.org/10.1016/S0140-6736(11)61344-5
,2011, 'Clinical photography in a high risk foot clinic: a quality audit', Journal of foot and ankle research, 4, pp. P58 - P58, http://dx.doi.org/10.1186/1757-1146-4-s1-p58
,2011, 'Microbiology culture results in high risk foot clinic patients: an audit', Journal of foot and ankle research, 4, pp. O50 - O50, http://dx.doi.org/10.1186/1757-1146-4-s1-o50
,2010, 'Overview of endocrinopathies associated with β-thalassaemia major', Internal Medicine Journal, 40, pp. 689 - 696, http://dx.doi.org/10.1111/j.1445-5994.2010.02254.x
,2000, 'A Risk Factor Screening and Assessment Protocol for Schizophrenia and Related Psychosis', Australian and New Zealand Journal of Psychiatry, 34, pp. S170 - S180, http://dx.doi.org/10.1080/000486700240
,2000, 'A Risk Factor Screening and Assessment Protocol for Schizophrenia and Related Psychosis', Australian & New Zealand Journal of Psychiatry, 34, pp. S170 - S180, http://dx.doi.org/10.1080/000486700240
,2000, 'A Risk Factor Screening and Assessment Protocol for Schizophrenia and Related Psychosis', Australian & New Zealand Journal of Psychiatry, 34, pp. A170 - A180, http://dx.doi.org/10.1177/000486740003401s26
,2021, 'The Effect Of Cannabidiol (CBD) On Exercise Physiology And Bioenergetics: A Randomised Controlled Pilot Trial', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, pp. 280 - 280
,2019, 'Denosumab, compared to standard care alone, reduces disease activity of acute diabetes related Charcot neuropathy', in 55th EASD Annual Meeting of the European Association for the Study of Diabetes Barcelona, Spain, 16 – 20 September 2019, Barcelona, Spain, pp. 1 - 600, presented at 55th Annual Meeting of the European Association for the Study of Diabetes, Barcelona, Spain, 16 September 2019 - 20 September 2019, http://dx.doi.org/10.1007/s00125-019-4946-6
,2023, 'A quarter year audit of admission, clinical and glycaemic characteristics of Inpatients with diabetes mellitus', Adelaide, South Australia, presented at Australasian Diabetes Congress 2023, Adelaide, South Australia, 23 August 2023 - 25 August 2023, http://dx.doi.org/10.26190/unsworks/31414
,2023, 'Characteristics of medication use and self-reported burden of therapy in those with diabetes mellitus complicated by diabetes foot disease', Adelaide, South Australia, presented at Australasian Diabetes Congress 2023, Adelaide, South Australia, 23 August 2023 - 25 August 2023, http://dx.doi.org/10.26190/unsworks/31413
,2023, 'Gut microbiota in Diabetic Foot Disease', Adelaide, South Australia, presented at Australasian Diabetes Congress 2023, Adelaide, South Australia, 23 August 2023 - 25 August 2023, http://dx.doi.org/10.26190/unsworks/31415
,2023, 'Preliminary results examining social, mental health and quality of life factors in diabetes foot disease', Adelaide, South Australia, presented at Australasian Diabetes Congress 2023, Adelaide, South Australia, 23 August 2023 - 25 August 2023, http://dx.doi.org/10.26190/unsworks/31412
,2023, 'Twelve-Month Cohort Analysis of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in People with Type 2 Diabetes Mellitus Admitted for Inpatient Care', Adelaide, South Australia, presented at Australasian Diabetes Congress 2023, Adelaide, South Australia, 23 August 2023 - 25 August 2023, http://dx.doi.org/10.26190/unsworks/31411
,2022, 'Clinical Characteristics of inpatients with diabetes mellitus and Sodium/glucose Cotransporter-2 Inhibitors who then develop Euglycemic Ketoacidosis', Brisbane, Queensland, presented at Australasian Diabetes Congress 2022, Brisbane, Queensland, 08 August 2022 - 10 August 2022, http://dx.doi.org/10.26190/unsworks/31422
,2022, 'DETECTING DIABETIC RETINOPATHY USING ARTIFICIAL INTELLIGENCE IN LIVERPOOL’S HIGH RISK FOOT SERVICE', Brisbane, Queensland, presented at Australasian Diabetes Congress 2022, Brisbane, Queensland, 08 August 2022 - 10 August 2022, http://dx.doi.org/10.26190/unsworks/31419
,2022, 'Preliminary Findings of study into Gut Microbiota in Diabetic Foot Disease', Brisbane, Queensland, presented at Australasian Diabetes Congress 2022, Brisbane, Queensland, 08 August 2022 - 10 August 2022, http://dx.doi.org/10.26190/unsworks/31421
,